Press Releases Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 Category All Releases Financial Releases Recro Pharma Announces Closing of $40 Million Public Offering of Common Stock Dec 16, 2016 9:27am EST Recro Pharma Announces Pricing of Public Offering of Common Stock Dec 13, 2016 9:10am EST Recro Pharma Announces Proposed Public Offering of Common Stock Dec 08, 2016 9:02am EST Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam Nov 28, 2016 7:00am EST Recro Pharma Reports Third Quarter 2016 Financial Results Nov 10, 2016 7:00am EST Recro Pharma to Present at Upcoming Investor Conferences Nov 09, 2016 7:00am EST Recro Pharma Presents Clinical Data at PAINWeek 2016 Sep 07, 2016 4:05pm EDT Recro Pharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference Sep 06, 2016 7:00am EDT Recro Pharma Announces Closing of Public Offering of Common Stock Aug 19, 2016 10:38am EDT Recro Pharma Announces Pricing of Public Offering of Common Stock Aug 16, 2016 9:00am EDT Prev 1... 8 9 10 11 12 13 14 15 16 17 Next
Recro Pharma Announces Closing of $40 Million Public Offering of Common Stock Dec 16, 2016 9:27am EST
Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam Nov 28, 2016 7:00am EST
Recro Pharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference Sep 06, 2016 7:00am EDT
